Search research articles
Contact Us
Filters
Showing results (31-40 of 68) with videos related to
Page
of 7
Sort By:
Plos One
|
August 23, 2012
Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults
Amanda Mocroft, Jacqueline Neuhaus, Lars Peters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 15, 2010
Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients
Markus Bickel, Nils von Hentig, Imke Wieters, et al.
AIDS (London, England)
|
June 19, 2010
Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients
Markus Bickel, Imke Wieters, Pavel Khaykin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 23, 2024
Vaccine-derived yellow fever in an immunocompromised patient on anti-CD20-antibody therapy and its treatment with sofosbuvir
Tobias Weirauch, Gerrit Burger, Dániel Cadar, et al.
European Journal of Immunology
|
November 28, 2012
Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library
Mingkui Zhou, Torsten Meyer, Stefanie Koch, et al.
The Journal of Antimicrobial Chemotherapy
|
June 26, 2014
Impact of raltegravir on HIV-1 RNA and DNA forms following initiation of antiretroviral therapy in treatment-naive patients
Christoph Stephan, Hanna-Mari Baldauf, Joanne Barry, et al.
The Journal of Infectious Diseases
|
October 2, 2002
Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression
Andrew N Phillips, Schlomo Staszewski, Fiona Lampe, et al.
Archives of Public Health = Archives Belges De Sante Publique
|
August 25, 2023
Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP study
Frederik Valbert, Uwe Koppe, Daniel Schmidt, et al.
The New England Journal of Medicine
|
May 6, 2026
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults
Isabel Leroux-Roels, Grace Huang, Murdo Ferguson, et al.
Medical Microbiology and Immunology
|
July 30, 2016
HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy
Maximilian Donath, Timo Wolf, Martin Stürmer, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 68) with videos related to
Sort By:
Page
of 7
Plos One
|
August 23, 2012
Hepatitis B and C co-infection are independent predictors of progressive kidney disease in HIV-positive, antiretroviral-treated adults
Amanda Mocroft, Jacqueline Neuhaus, Lars Peters, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
December 15, 2010
Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients
Markus Bickel, Nils von Hentig, Imke Wieters, et al.
AIDS (London, England)
|
June 19, 2010
Low rate of seroconversion after vaccination with a split virion, adjuvanted pandemic H1N1 influenza vaccine in HIV-1-infected patients
Markus Bickel, Imke Wieters, Pavel Khaykin, et al.
International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
|
March 23, 2024
Vaccine-derived yellow fever in an immunocompromised patient on anti-CD20-antibody therapy and its treatment with sofosbuvir
Tobias Weirauch, Gerrit Burger, Dániel Cadar, et al.
European Journal of Immunology
|
November 28, 2012
Identification of a new epitope for HIV-neutralizing antibodies in the gp41 membrane proximal external region by an Env-tailored phage display library
Mingkui Zhou, Torsten Meyer, Stefanie Koch, et al.
The Journal of Antimicrobial Chemotherapy
|
June 26, 2014
Impact of raltegravir on HIV-1 RNA and DNA forms following initiation of antiretroviral therapy in treatment-naive patients
Christoph Stephan, Hanna-Mari Baldauf, Joanne Barry, et al.
The Journal of Infectious Diseases
|
October 2, 2002
Human immunodeficiency virus rebound after suppression to <400 copies/mL during initial highly active antiretroviral therapy regimens, according to prior nucleoside experience and duration of suppression
Andrew N Phillips, Schlomo Staszewski, Fiona Lampe, et al.
Archives of Public Health = Archives Belges De Sante Publique
|
August 25, 2023
Optimization of HIV testing services in Germany using HIV indicator diseases: study protocol of the HeLP study
Frederik Valbert, Uwe Koppe, Daniel Schmidt, et al.
The New England Journal of Medicine
|
May 6, 2026
Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults
Isabel Leroux-Roels, Grace Huang, Murdo Ferguson, et al.
Medical Microbiology and Immunology
|
July 30, 2016
HIV-1 replication in central nervous system increases over time on only protease inhibitor therapy
Maximilian Donath, Timo Wolf, Martin Stürmer, et al.
Page
of 7